Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 3, 2010, Pages 254-

  Godoy, Heidi ^a   Kesterson, Joshua P ^a   Lele, Shashikant ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Recurrent endometrial cancer; Tumor lysis syndrome

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; PACLITAXEL;

ABDOMINAL TENDERNESS; ADULT; ARTICLE; ATELECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIALYSIS; DYSPNEA; ENDOMETRIUM CANCER; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; HYPOTENSION; METABOLIC DISORDER; PRIORITY JOURNAL; RECURRENT CANCER; SEPTICEMIA; TACHYCARDIA; TUMOR LYSIS SYNDROME; WEAKNESS;

EID: 77951640336     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.02.005     Document Type: Article

References (4)

1. Baeksgaard L., and Sorensen J.B. Acute tumor lysis syndrome in solid tumors. Cancer Chemother Pharmacol 51 3 (2003) 187-192
2. Chan J.K., Lin S.S., McMeekin D.S., and Berman M.L. Patients with malignancy requiring urgent therapy: Case 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. J Clin Oncol 23 27 (2005) 6794-6795
3. Yahata T., Nishikawa N., Aoki Y., and Tanaka K. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer. Gynecol Oncol 103 2 (2006) 752-754
4. Rampello E., Fricia T., and Malaguarnera M. The management of tumor lysis syndrome. Nat Clin Pract Oncol 3 8 (2006) 438-447